HPV vaccine found to prevent childhood respiratory papillomatosis
The vaccine that protects against cancer-causing types of human papillomavirus also prevents an uncommon but incurable childhood respiratory disease...
List view / Grid view
The vaccine that protects against cancer-causing types of human papillomavirus also prevents an uncommon but incurable childhood respiratory disease...
A vaccine combining centralised ancestral genes from four major influenza strains appears to provide broad protection against influenza...
Universal Influenza Vaccine Initiative will address the underlying scientific barrier impeding the development of broadly protective, universal influenza vaccines...
Scientists are developing a vaccine by targeting strains of S. pneumoniae...
Leukaemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals...
Clinical trial results show that two candidate Ebola vaccines can elicit immune responses after initial vaccination that last for at least one year...
Dante J Marciani, President and CSO of Qantu Therapeutics, reviews the current evidence and controversy in the hunt for a vaccine against Alzheimer's disease and considers the future.
Results from a Phase 3 efficacy study in India of the rotavirus vaccine Rotasil showed the vaccine to be safe, against severe rotavirus gastroenteritis...
Researchers have examined the relationship between the HPV vaccination and fertility and identified that the vaccine can improve chances of conception...
Engineers have invented a new 3-D fabrication method that can generate a novel type of drug-carrying particle that could allow multiple doses of a drug or vaccine to be delivered...
Scientists have developed an improved vaccine commonly associated with cervical cancer...
A patient trial for KAF156, a next-generation antimalarial compound with the potential to treat drug-resistant strains of the malaria parasite has been launched...
Duke researchers used a bivalent virus from chicken cells that packaged twice as much protein as a monovalent virus, and vaccinated mice with either the bivalent or monovalent vaccine
Small skin patches with dissolvable microneedles were safe and well-tolerated, generated robust immunity against influenza, could be self-administered by study participants and were strongly preferred over shots.
12 May 2017 | By Niamh Marriott, Junior Editor
St. Jude Children’s Research Hospital and the Serum Institute of India will develop & commercialise a vaccine against the respiratory syncytial virus (RSV).